Pathogenic variant of RBM20 in a multiplex family with hypertrophic cardiomyopathy

Natsuko Inagaki1,2, Takeharu Hayashi3,4, Yasuyoshi Takei5

  • 1Department of Cardiology, Tokyo Medical University, Tokyo, Japan. abenatsu@wb3.so-net.ne.jp.

Human Genome Variation
|February 19, 2022
PubMed

Insights

RNA-binding protein 20 (RBM20) variants are linked to hypertrophic cardiomyopathy (HCM). A specific RBM20 variant, p.Arg636His, previously associated with dilated cardiomyopathy (DCM), was identified in a family with HCM, suggesting a novel role for RBM20 in HCM.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Genetic Etiology of Cardiomyopathies

Background:

  • RNA-binding protein 20 (RBM20) is primarily known as a disease-causing gene for dilated cardiomyopathy (DCM).
  • Familial hypertrophic cardiomyopathy (HCM) has diverse genetic underpinnings, but novel causative genes are continually being identified.
  • The p.Arg636His missense variant in RBM20 has been previously reported as pathogenic in families with DCM.

Purpose of the Study:

  • To investigate the genetic basis of familial hypertrophic cardiomyopathy (HCM) in a family.
  • To determine if the RBM20 gene and its variants play a role in the pathogenesis of HCM.
  • To evaluate the p.Arg636His variant of RBM20 as a potential causative factor for familial HCM.

Main Methods:

  • Clinical evaluation of proband and family members presenting with hypertrophic cardiomyopathy (HCM).
  • Genetic sequencing to identify variants in candidate genes, including RBM20.
  • Segregation analysis of the identified RBM20 variant within the affected family.

Main Results:

  • The proband presented with the dilated phase of hypertrophic cardiomyopathy (HCM).
  • The mother of the proband also had a history of hypertrophic cardiomyopathy (HCM).
  • Both the proband and the mother carried the RBM20 p.Arg636His missense variant, which was previously associated with dilated cardiomyopathy (DCM).

Conclusions:

  • The RBM20 p.Arg636His variant is a potential causative factor for hypertrophic cardiomyopathy (HCM) in this familial case.
  • RBM20 may represent a novel causative gene for hypertrophic cardiomyopathy (HCM), expanding its known clinical spectrum beyond DCM.
  • Further research is warranted to elucidate the precise mechanisms by which RBM20 variants contribute to HCM pathogenesis.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
78
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
101
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
50
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
77
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
73
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.2K